ZFPM2-AS1 is significantly upregulated in SCLC tissues and cells, and TRAF4 reverses ZFPM2-AS1 downregulation-mediated proliferation and invasion of SCLC cells in vitro and tumor function of growth (65). The gene discussed is TRAF4; the disease is neoplasm.